New Horizon Health Ltd
New Horizon Health Ltd exhibits a capital structure with a debt-to-equity ratio of 0.12, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 8.8, suggesting strong short-term liquidity. However, the company's operating cash flow is negative at -412,538,000 CNY, and free cash flow is also negative at -107,825,000 CNY, indicating challenges in generating positive cash from operations. Profitability metrics show that the company is currently unprofitable, with a net loss of 80,313,000 CNY and an operating loss of 72,297,000 CNY. Return on equity is -3.79%, and return on assets is -3.12%, both significantly below the industry median for medical equipment and supplies distribution. Gross profit of 646,170,000 CNY represents a healthy margin, but this is insufficient to offset operating and net losses. The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or segment concentration risks. However, the company's total revenue of 764,960,000 CNY is derived from its core operations in the medical equipment and supplies distribution sector. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue and profitability, with no clear indication of improvement in the next fiscal year. The company's capital expenditure of -53,838,000 CNY suggests ongoing investment in infrastructure, but the negative operating and free cash flows indicate that these investments are not yet generating positive returns. Risk factors include a medium liquidity risk due to negative operating and free cash flows, and a key flag indicating that net cash is negative after subtracting total debt. The company's dilution risk is assessed as low, with no immediate pressure for share issuance. However, the company's unprofitable status and negative cash flows suggest potential for future dilution if capital needs increase. Recent events include the latest actual EPS of -0.19 CNY and actual revenue of 764,960,000 CNY, both reported in the most recent financial filings. These figures highlight the company's current financial challenges and the need for strategic improvements to achieve profitability and positive cash flow.
Business. New Horizon Health Ltd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products and services.
Classification. New Horizon Health Ltd is classified under the Healthcare economic sector, specifically in the Healthcare Services & Equipment business sector, with a high confidence level of 0.92.
- New Horizon Health Ltd is currently unprofitable with a net loss of 80,313,000 CNY and an operating loss of 72,297,000 CNY.
- The company's liquidity position is strong with a current ratio of 8.8, but it faces challenges in generating positive operating and free cash flows.
- The company's debt-to-equity ratio of 0.12 indicates a relatively low reliance on debt financing.
- The company's return on equity and return on assets are significantly below the industry median, indicating poor profitability.
- The company's growth trajectory is uncertain, with no clear indication of improvement in the next fiscal year.
- # RATIONALES
- **margin_outlook_rationale**: The company's gross margin is healthy, but the operating and net losses indicate that cost management and operational efficiency need improvement to enhance profitability.
- **rd_outlook_rationale**: There is no specific information provided about the company's research and development activities or their impact on future growth.
- Net cash is negative after subtracting total debt.